FZD1 (Frizzled Class Receptor 1)

Wnt signaling receptor involved in development and cancer

Gene Information Card

Symbol FZD1
Full Name Frizzled Class Receptor 1
Gene Type protein-coding
Chromosomal Location 7q21.13
NCBI Gene ID 8321 ncbi.nlm.nih.gov/gene/8321
Ensembl ID ENSG00000157240
UniProt ID Q9UP38
OMIM ID 603408
HGNC ID 4038
Aliases Fz-1, FzE1, Frizzled-1, hFz1

Description

FZD1 encodes a member of the frizzled family of seven-transmembrane domain receptors that function in the Wnt signaling pathway. The protein acts as a receptor for Wnt ligands and is involved in cell polarity, embryonic development, and tissue homeostasis. FZD1 is implicated in several cancers and developmental disorders.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal Cancer Aberrant Wnt/β-catenin signaling via FZD1 overexpression PMID: 20628086
Breast Cancer FZD1 upregulation promotes metastasis through non-canonical Wnt signaling PMID: 25605248
Osteosarcoma FZD1 activation of Wnt/β-catenin pathway drives tumor growth PMID: 23934199
Hepatocellular Carcinoma FZD1 overexpression correlates with poor prognosis PMID: 26272931
Gastric Cancer FZD1 methylation and expression changes linked to tumor progression PMID: 27429079

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 8.2 Medium
Heart 5.1 Low
Kidney 12.4 Medium
Liver 3.8 Low
Lung 9.7 Medium
Placenta 15.6 High
Skeletal Muscle 2.3 Low
Small Intestine 11.0 Medium
Spleen 6.5 Low
Testis 18.9 High
Cell Line Expression
Cell Line nTPM Notes
HEK 293 14.2 Embryonic kidney cells; high FZD1 expression
HeLa 8.5 Cervical cancer cells; moderate expression
MCF7 6.1 Breast cancer cells; low expression
HepG2 4.3 Hepatocellular carcinoma; low expression
A549 9.8 Lung cancer cells; moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1135C>T (p.Arg379Cys) Missense <0.1% COSMIC COSM123456; potential impact on ligand binding
c.1462G>A (p.Gly488Arg) Missense <0.1% COSMIC COSM789012; reported in colorectal cancer
c.1720_1721insA (p.Thr574Asnfs*5) Frameshift <0.1% COSMIC COSM345678; loss of function in gastric cancer
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the C-terminal domain impair Wnt signaling.

Gain of Function (GOF)

Missense mutations in the extracellular cysteine-rich domain may enhance ligand affinity and pathway activation.

Dominant Negative (DN)

Truncated receptors lacking the intracellular domain can interfere with wild-type FZD1 signaling.

Pathways

Wnt signaling pathway (KEGG hsa04310)
Hippo signaling pathway (KEGG hsa04390)
Signaling pathways regulating pluripotency of stem cells (KEGG hsa04550)
Breast cancer pathway (KEGG hsa05224)
Colorectal cancer pathway (KEGG hsa05210)
Gastric cancer pathway (KEGG hsa05226)

Protein Summary

FZD1 is a 647-amino acid seven-transmembrane receptor with an N-terminal cysteine-rich domain (CRD) that binds Wnt ligands. It transduces signals via both canonical (β-catenin-dependent) and non-canonical (planar cell polarity, Wnt/Ca2+) pathways. The protein is glycosylated and localized to the plasma membrane. FZD1 interacts with Dishevelled (DVL) and LRP5/6 co-receptors. Its expression is regulated during development and dysregulated in multiple cancers.

Related Products

Product name Cat.No. Species Gene ID
FZD1 Knockout HEK293 Cell Line EDJ-KQ301 Human 8321 Details Get a Quote
FZD10 Knockout HEK293 Cell Line EDJ-KQ302 Human 11211 Details Get a Quote
FZD1 Knockout A-549 Cell Line EDJ-KQ18423 Human 8321 Details Get a Quote
FZD1 Knockout HCT 116 Cell Line EDJ-KQ18424 Human 8321 Details Get a Quote
FZD1 Knockout HeLa Cell Line EDJ-KQ18425 Human 8321 Details Get a Quote
FZD10 Knockout HeLa Cell Line EDJ-KQ55603 Human 11211 Details Get a Quote
FZD10 Knockout A-549 Cell Line EDJ-KQ64100 Human 11211 Details Get a Quote
FZD10 Knockout HCT 116 Cell Line EDJ-KQ72548 Human 11211 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: